Barañao RI

No ORCID on file · 23 papers in corpus
lab-animal 2025
Biomedicines ·doi:10.3390/biomedicines13020348

Background/Objectives: Endometriosis has a marked impact on fertility, although the mechanisms behind this relationship remain poorly understood, particularly in cases without significant anatomical distortions or in the context of ovarian …

lab-animal 2025
·doi:10.20944/preprints202501.0736.v1

Background/Objectives: Endometriosis has a marked impact on fertility, although the mechanisms behind this relationship remain poorly understood, particularly in cases without significant anatomical distortions or in the context of ovarian …

lab-animal 2022
European journal of clinical investigation ·doi:10.1111/eci.13899

BACKGROUND: Dysregulated hyaluronic acid (HA) metabolism has been shown to be implicated in several pathologies including endometriosis. 4-Methylumbelliferone (4MU) is an HA synthesis inhibitor with proven antitumour activity. In this study…

lab-animal 2022
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2022.02.008

RESEARCH QUESTION: Does resveratrol exert a potent inhibitory effect on the development of endometriosis by interfering with some pivotal processes? DESIGN: In-vitro cultures of primary endometriotic stromal cells, immortalized endometrial…

lab-animal 2021
Food & function ·doi:10.1039/d1fo01702k

Endometriosis is an often painful disease in reproductive-aged women, in which endometrial-like tissue grows outside the uterine cavity. Since the limited current therapeutic alternatives fail in alleviating the symptoms and based on our pr…

lab-animal 2021
Human Reproduction ·doi:10.1093/humrep/deab053

STUDY QUESTION: What are the effects of plant-derived antioxidant compounds urolithin A (UA) and B (UB) on the growth and pathogenetic properties of an in vitro endometriosis model? SUMMARY ANSWER: Both urolithins showed inhibitory effects…

observational 2019
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology ·doi:10.1080/09513590.2019.1680627

Based on the inflammatory nature and hormone-dependency of endometriosis, PI3K/AKT signaling appears to influence its progression. Could the endometriosis stages be linked to differential changes in PI3K/AKT pathway regulation? The objectiv…

lab-animal 2016
PloS one ·doi:10.1371/journal.pone.0152302

BACKGROUND: The development and long-term survival of endometriotic lesions is crucially dependent on an adequate vascularization. Hyaluronic acid (HA) through its receptor CD44 has been described to be involved in the process of angiogenes…

lab-animal 2015
PloS one ·doi:10.1371/journal.pone.0124900

OBJECTIVES: To evaluate the effect of endometriosis on fertility and the levels of the IL-2 and IFN-γ in the peritoneal fluid in a mouse model; to evaluate the effect of pregnancy on endometriotic lesion growth, apoptosis and cell prolifera…

lab-animal 2014
The Journal of Pathology ·doi:10.1002/path.4397

Endometriosis is characterized by the presence of endometrial tissue outside the uterus that causes severe pelvic pain and infertility in women of reproductive age. Although not completely understood, the pathophysiology of the disease invo…

lab-animal 2012
Reproduction (Cambridge, England) ·doi:10.1530/rep-12-0386

Endometriosis is a benign gynecological disease. Cyclooxygenase-2 (COX-2) and aromatase proteins have been shown to be overexpressed in eutopic endometrium from women suffering from this disease compared to disease-free women. Furthermore, …

lab-animal 2012
Human Reproduction ·doi:10.1093/humrep/des369

STUDY QUESTION: Can resveratrol and epigallocatechin-3-gallate (EGCG) inhibit the growth and survival of endometriotic-like lesions in vivo in a BALB/c model of endometriosis, and in vitro in primary cultures of human endometrial epithelial…

lab-animal 2011
Reproductive sciences (Thousand Oaks, Calif.) ·doi:10.1177/1933719110395406

The main factor involved in neovascularization of ectopic endometrial tissue in endometriosis is the vascular endothelial growth factor (VEGF), which is produced both by the endometrial implant and by peritoneal macrophages. On the other ha…

lab-animal 2011
Fertility and sterility ·doi:10.1016/j.fertnstert.2011.05.063

OBJECTIVE: To evaluate the effects of celecoxib and rosiglitazone on the implantation and growth of endometriotic-like lesions in a murine model of endometriosis. DESIGN: Prospective experimental study. SETTING: Animal research and labora…

lab-animal 2010
Journal of Reproductive Immunology ·doi:10.1016/j.jri.2009.12.002

The aim of this study was to evaluate the effect of vascular endothelial growth factor (VEGF) and interleukin-1beta (IL-1beta) on apoptosis induced by leuprolide acetate (LA) in endometrial epithelial cell cultures from patients with endome…

lab-animal 2009
Fertility and sterility ·doi:10.1016/j.fertnstert.2009.08.058

OBJECTIVE: To evaluate the effect of aromatase inhibitors on ectopic endometrial growth and on the release of proangiogenic and proinflammatory factors in peritoneal fluid (PF). DESIGN: Prospective experimental study. SETTING: Animal rese…

review 2008
Gynecologic and obstetric investigation ·doi:10.1159/000148026

It has been postulated that gonadotropin-releasing hormone (GnRH) analogues may act directly on endometrial cells and inhibit their growth and proliferation by regulation of apoptotic and angiogenic mechanisms. Eutopic endometrial cells fro…

lab-animal 2007
Human Reproduction ·doi:10.1093/humrep/del423

BACKGROUND: Our purpose was to evaluate the effect of the GnRH agonist (GnRHa), leuprolide acetate (LA), and the GnRH antagonist (GnRHant), Antide, on apoptosis and expression of apoptosis-related proteins in endometrial epithelial cell (EE…

lab-animal 2003
Human Reproduction ·doi:10.1093/humrep/deg356

BACKGROUND: The aim of the present study was to evaluate the effect of GnRH analogues on the in-vitro eutopic endometrial cell apoptosis and release of interleukin-1beta (IL-1beta) and vascular endothelial growth factor (VEGF). METHODS: Bi…

lab-animal 2003
Fertility and sterility ·doi:10.1016/s0015-0282(03)00769-6

OBJECTIVE: There is growing evidence that suggests a direct action of gonadotropin-releasing hormone agonist (GnRH-a) on endometrial growth. Consequently, our purpose was to evaluate the effect of GnRH-a on in vitro eutopic endometrial cell…

nonrandomized-trial 2002
Fertility and sterility ·doi:10.1016/s0015-0282(02)03099-6

OBJECTIVE: To evaluate the effects of administering combination oral contraceptives (COCs) to patients with endometriosis on the regulation of cell growth in the eutopic endometrium. DESIGN: Prospective study. SETTING: Research institute …

observational 1998
Archives of gynecology and obstetrics ·doi:10.1007/s004040050214

The aim of this study was to elucidate whether peritoneal macrophage (pMO) alterations are a generalized feature in all stages of endometriosis and the effect of hormonal treatment on this leukocyte population. For this purpose we quantifie…

lab-animal 1997
Archives of gynecology and obstetrics ·doi:10.1007/bf02505318

The aim of this study was to evaluate and compare the mitogenic effect of peritoneal fluid (PF) from women with mild and severe endometriosis on the endometrial stromal cell proliferation. Increasing concentrations of PF from women with and…